News Releases

Research by Einstein Scientists Featured in Special Issue of Diabetes Care
Einstein Community Celebrates Pi Day
Einstein Community Celebrates Pi Day
Iron Restriction Keeps Blood Stem Cells Young

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Eric E. Bouhassira

Eric E. Bouhassira, Ph.D.

Area(s) of expertise: Stem cell researchBlood-forming stem cellsCell therapy

Dr. Bouhassira’s work focuses on prompting human embryonic stem cells to develop into hematopoietic (blood-forming), as well as stem cells, and into red blood cells. This work could potentially help patients needing transfusions and save lives by… Learn more

Einstein in the News

The New York Times
$1 Billion Donation Will Provide Free Tuition at a Bronx Medical School

Ruth Gottesman, Ed.D., chair of the Einstein Board of Trustees and Montefiore Health System board member, has donated $1 billion dollars to Einstein— the largest gift made to any medical school in the country—ensuring free tuition in perpetuity. Dr. Gottesman is also professor emerita of pediatrics.

Additional coverage includes The Wall Street Journal, The Washington Post, The Associated Press, CBS News, ABC News, NBC New York, BBC, The Guardian, Forbes, Fortune, and The Hill

Technology Networks
The Next Chapter of Science

Xingxing Zang, Ph.D., says chimeric antigen receptor (CAR)-immune cell therapy, particularly CAR-T therapy, is a major advancing field with potential to revolutionize cancer treatment, particularly for leukemia and lymphoma. Dr. Zang is a member of the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), and professor of microbiology & immunology, of oncology, of medicine, and of urology, and the Louis Goldstein Swan Chair in Cancer Research at Einstein.

What Is a Typical Degree of Cognitive Ability For a Person In Their 80s?

Nir Barzilai, M.D., says 2024 presidential candidates Joe Biden and Donald Trump, whose parents lived over 90, may be aging more slowly than people who do not have longevity in their family. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.

More coverage on Dr. Barzilai


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos